KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

TICLID 250 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

250 MG

 

GENERIC NAME:

TICLOPIDINE

 

MANUFACTURER:

SANOFI WINTHROP

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Stroke, thrombotic, prevention

Thrombosis, stent, prevention

 

SIDE EFFECTS:

Skin rash

Bleeding complications

itching of skin

neutropenia, including agranulocytosis

purpura

Hepatitis or cholestatic jaundice

hives

ringing or buzzing in ears

skin rash, severe, including erythema multiforme

Stevens-Johnson syndrome

exfoliative dermatitis

thrombocytopenia

thrombotic thrombocytopenic purpura

Abdominal pain

diarrhea

indigestion

nausea

Bloating or gas

dizziness

vomiting

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Any condition in which there is a significant risk of bleeding

Gastrointestinal ulceration

Surgery

Trauma

>> Renal function impairment, severe

 

ADULT DOSE:

Antithrombotic- Oral, 250 mg twice a day, taken with food .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Safety and efficacy in patients up to 18 years of age have not been established .  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

Antithrombotic- Oral, 250 mg twice a day, taken with food .

 

 

PREVIOUS

  

NEXT